PATENT CLAIM ANALYSIS

Application Number: 15780398
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "275000"]

Abstract:
The disclosure includes a method of inducing direct reprogramming (transdifferentiation) into non-oncogenic cells accompanied by tumor cell apoptosis in human tumor cells using a small molecule composition, based on the mechanism of chemical-induction of direct cellular reprogramming. The disclosure also includes a small molecule composition used for the method, and culture media and agents prepared from the composition.

Claim (Index 10):
A method for inducing reprogramming or transdifferentiation of tumor cells directly into non-oncogenic cells and accompanying tumor cell apoptosis, wherein the method includes treating the human tumor cells with a composition according to any one of  claims 1 - 8 , so that the human tumor cells are reprogrammed directly into non-oncogenic cells, which is accompanied by tumor cell apoptosis.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.48837
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13697274', '15376536', '13704214', '15446552', '15072769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7782188687646826
- 35 USC 102 Novelty (BERT): 0.5161659868826345
- Combined Prediction Score: 0.7520135805764777
- Mean Citation Score: 247.068706
- Max Citation Score: 257.53943
- Similarity Product: 153.08585522657336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test